Trial
NCT02403622
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Microbiome Health Research Institute
Collaborators
Brown University; Edward Hospital; Indiana University; Tufts Medical Center
Condition
Clostridium Difficile
Intervention
Fecal Microbiota Preparation
Why stopped
for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-23